HomeProduct Categories
Filter by Product Type
- Clear Filters
Filter by Target / Protein
- Clear Filters
shRNA Lentiviral Particles for Kinases
| Catalog Number | Product Name | Product Size | Species | Applications | Price |
|---|---|---|---|---|---|
| KGE0001-SL-2 | shRNA Lentiviral Particles for 2810408M09Rik (Mouse) | 200 µl | Mouse | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0002-SL-1 | shRNA Lentiviral Particles for AAK1 (Human) | 200 µl | Human | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0002-SL-2 | shRNA Lentiviral Particles for AAK1 (Mouse) | 200 µl | Mouse | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0003-SL-1 | shRNA Lentiviral Particles for AATK (Human) | 200 µl | Human | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0003-SL-2 | shRNA Lentiviral Particles for AATK (Mouse) | 200 µl | Mouse | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0004-SL-1 | shRNA Lentiviral Particles for ABL2 (Human) | 200 µl | Human | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0004-SL-2 | shRNA Lentiviral Particles for ABL2 (Mouse) | 200 µl | Mouse | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0005-SL-1 | shRNA Lentiviral Particles for ABR (Human) | 200 µl | Human | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0005-SL-2 | shRNA Lentiviral Particles for ABR (Mouse) | 200 µl | Mouse | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
| KGE0006-SL-1 | shRNA Lentiviral Particles for ACK (Human) | 200 µl | Human | Gene Silencing. High-titer lentiviral particles sufficient for 10-20 transductions. | Inquiry |
For research use only. Not intended for any clinical use.